Updated Jul 16, 2026
Maunsell Farris Maryanne has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Maunsell Farris Maryanne is the Vice President and Chief Accounting Officer of Haemonetics Corporation, a publicly traded medical devices company that provides blood management solutions. In this capacity, she oversees accounting, financial reporting, internal controls, and related compliance. The SEC filings indicate her role at Haemonetics as of the most recent filing date (May 19, 2026).
| Role | VP, Chief Accounting Officer |
|---|---|
| Notability | 65/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-08 | HAE | HAEMONETICS CORP | F — Tax withholding / forfeiture | 259 | $71.28 | $18K |
| 2026-05-19 | HAE | HAEMONETICS CORP | A — Grant or award | 2.2K | — | |
| 2026-05-19 | HAE | HAEMONETICS CORP | F — Tax withholding / forfeiture | 197 | $56.29 | $11K |
Maunsell Farris Maryanne is the Vice President and Chief Accounting Officer of Haemonetics Corporation, a publicly traded medical devices company that provides blood management solutions. In this capacity, she oversees accounting, financial reporting, internal controls, and related compliance. The SEC filings indicate her role at Haemonetics as of the most recent filing date (M…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Maunsell Farris Maryanne profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.